NASH and Liver Fibrosis

Our product portfolio for Non-Alcoholic Steatohepatitis (NASH) and liver fibrosis research provides a comprehensive range of human primary liver cells and specialized ECM matrices for modeling fibrotic liver disease. We offer high-quality primary hepatocytes, hepatic stellate cells (quiescent and activated), Kupffer cells, and liver endothelial cells sourced from both healthy and fibrotic livers.